HBOT 2019: 13TH ANNUAL HYPERBARIC MEDICINE SYMPOSIUM
* ALL LINKS TO CONDITIONS (RESTRICTED REPRESENTATIONS) OR PRODUCTS THAT HAVE NOT CONFORMED TO PRE REGISTRATION APPROVAL ARE REMOVED AT THE DIRECTION OF THE AUSTRALIAN THERAPEUTIC GOODS ADMINISTRATION (16 JUNE 2020)
September 27th, 28th, and 29th | Charleston, South Carolina
* The HBOT 2019 3-day conference will introduce the very latest science, protocols, case studies, and treatments delivered by experienced and respected speakers from the United States and around the world.
HBOT 2019 webpage: https://www.hyperbaricmedicineinternational.org/hbot-conference
Malcolm R. Hooper - International Executive Director and a member of the Hyperbaric Medicine International Board.
Caveat: This is not an advertisement or an endorsement of treatment.
Lt. General Michael T. Flynn, USA, (Ret.)
General Flynn will speak to service and sacrifice and what each means to those who serve, and willingly go in harm’s way. Their experiences facing the realities of combat must never be forgotten, especially those who have paid the ultimate sacrifice. We, as a nation and as communities, must develop new ideas and try fresh, bold approaches to helping our military and our Veterans succeed.
Lieutenant General (US Army) Retired, Michael “Mike” Flynn served as the National Security Advisor to the 45th President of the United States of America and over 33 years in the United States Army rising to the highest military intelligence position in the Department of Defense. Mike holds three master’s degrees and two honorary doctorates and is considered one of the nation’s foremost experts on national security, foreign policy, intelligence and security issues. He has spoken on a variety of topics to both U.S. and international audiences and has lectured at numerous universities and colleges. Mike’s passion is to help fellow Veterans and the challenges they face ranging from integration into civil society to the effects of wartime injuries and how they impact their overall healthcare challenges.
Lt. General Flynn will also participate in a roundtable discussion, with selected leaders and invited delegates to a real-time question and answer forum that will be a once in a lifetime experience.
General Flynn will play a key role in helping to spark a discussion about the challenges that so many of our Veterans face. Technologies and therapies such as (TGA REMOVED) low level light, neurofeedback, and advances in digital brain filming, to name a few, can be instrumental in helping Veterans with (TGA REMOVED) and even address the dramatically high rate of Veteran suicides. We can all contribute to this important discussion, and ultimately the solution.
Joseph C. Maroon, MD
Joseph Maroon MD is clinical professor, Vice Chairman and Heindl Scholar in Neuroscience in the Department of Neurosurgery at the University of Pittsburgh Medical Center. His medical and surgical training was obtained at Indiana, Georgetown, and Oxford (England) Universities, and the University of Vermont.
He has published over 283 peer reviewed papers, 64 book chapters and 7 books dealing with the prevention and treatment of traumatic injuries to the brain and spinal cord in athletics; minimally invasive approaches to brain and spinal diseases; and complimentary approaches to inflammatory diseases associated with aging.
Dr. Maroon co-developed ImPACT, a neurocognitive test for concussion management, which is the only FDA approved test (2016) for concussion evaluation. Over 13 million athletes have been tested to date.
He is on the editorial boards of Neurological Research, The Physician and Sportsmedicine, Surgical Neurology International, and others.
Athletically he was a Scholastic All American in football at Indiana University, has participated in 80 triathlons, and completed 8 Ironman distance races (2.4 mile swim, 112 mile bike, 26.2 mile run), the last in 2017.
For the past 30 years Dr. Maroon has been the team neurosurgeon for The Pittsburgh Steelers, and the first neurosurgeon directly appointed in the NFL. Since 2007 he has been a member of the NFL Head, Neck and Spine Committee. He is also the medical director for the WWE, and Chairman of the Scientific Advisory Committee for the Chuck Noll Foundation for Brain Injury Research.
Honors include: President of the International Congress of Neurological Surgery, Indiana University Distinguished Alumnus, and inductee into the Lou Holtz and National Fitness Halls of Fame. In 2018 he received the Humanitarian of the Year Award from the Jerome Bettis Foundation.
State Senator Tom A. Wright
Senator Wright was elected to the Senate in 2018 and represents Senate District 14, which consists of parts of Brevard and Volusia Counties. He currently serves as Chair of the Senate Committee on Military and Veterans Affairs and Space. He also serves on four additional committees; The Committee on Children, Families and Elder Affairs; Commerce and Tourism; Environment and Natural Resources and the Joint Administrative Procedures Committee. He is Co-Chair of the Florida Space Caucus.
During the 2019 Legislative Session, Senator Wright’s Alternative Treatment Options for Veterans passed the Florida Legislature. This bill will allow for a study to review alternative avenues for veterans who currently suffer from service connected injuries that have resulted in diagnoses of post-traumatic stress disorder or traumatic brain injury. It is awaiting the Governor’s signature.
Senator Wright brings his own experiences to the table, having personally sponsored eight veterans to receive hyperbaric oxygen therapy; one of the five listed treatments in the bill. Of those veterans, all eight healed with resounding success.
Growing up in Minnesota, Senator Wright always was an entrepreneur. Starting in business for himself at age 23 he grew many various companies to successful futures. In his 50’s he became more involved in serving others as his abilities and resources provided.
Throughout his personal life, Senator Wright has dedicated his time and effort to provide support on issues relating to our veterans, to eliminate the domestic abuse of women, children and animals. Now as a State Senator, he strives to make a positive difference in our great State of Florida.
Senator Wright moved to Florida in 2004 with his wife Cindy and they live in New Smyrna Beach, FL.
Changing the Treatment Paradigm of Trauma with rTMS Therapy
Ryan J. Wakim, MD
Ryan Wakim is a psychiatrist who works to expand access to mental health care, addiction, and innovative treatments. Dr. Wakim sits as the acting President and CEO of an emerging behavioral health corporation, which includes TransforMationS. He regularly consults with numerous hospital systems, state boards, and criminal justice programs to develop standards of care rooted in evidence-based medicine, advancing mental health treatment within the region.
As a board-certified psychiatrist, Dr. Wakim specializes in human interaction, complex problem solving, and both cognitive and behavioral theories. He has used Neurostar TMS therapy for patients in his practice beginning in October 2017. The life-changing results he has seen since that time, including with a member of his own family, has provided him with patient outcomes and experiences never imagined with medications and therapy alone.
HBOT in the treatment of chronic Traumatic Brain Injury
HBOT Dosing for Neurological Conditions
Dr. Paul Harch, MD
Dr. Harch is a world-recognized leading expert in hyperbaric medicine with one of the largest practices in neurological hyperbaric medicine. He is a Clinical Professor of Medicine at Louisiana State University School of Medicine, Director of Hyperbaric Medicine at University Medical Center, New Orleans, which was opened in August, 2015, and former Director of the LSU Hyperbaric Medicine Fellowship. He has presented nearly 200 lectures on hyperbaric medicine and authored more than 70 academic publications.
Dr. Harch will be giving lectures on the results of a randomized trial of HBOT in the treatment of (TGA REMOVED) that is the culmination of 30 years of clinical treatment and research, and a unifying lecture on hyperbaric medicine dosing across the entire spectrum of pressure and hyperoxia. The second lecture will seamlessly meld normobaric oxygen therapy with the Russian experience, "mild" hyperbaric therapy, and traditional hyperbaric therapy dosing.
Dr. Harch serves as the Chairperson of Hyperbaric Medicine International's Scientific Advisory Committee.
HBOT...a living testimony
Brigadier General Patt Maney, USA, (Ret.)
An ROTC graduate, General Maney served almost 37 years in the Army Reserve, including over eight years of active duty with service in Panama, Haiti, Bosnia and Afghanistan. In Bosnia, he served at the Office of the High Representative, an international peace implementation organization established by the Dayton Peace Accord, ultimately serving as the acting chief of staff. In Afghanistan, he was the senior advisor for the political sector for the US Ambassador and held the diplomatic rank of attaché. After 17 months in country, he was wounded in an IED blast and spent almost 20 months at Walter Reed Army Hospital. After a year as a patient at Walter Reed a physician family friend suggested he try hyperbaric oxygen therapy. He credits HBOT with “giving him his life back” and allowing him to complete a fulfilling judicial career with service to fellow veterans, teaching him that, “Hard Times Bring Good Things”. Among his major military awards are the Legion of Merit, the Bronze Star and the Purple Heart.
Maney currently serves as Civilian Aide to the Secretary of the Army (Florida-North) and on the Florida Supreme Court’s Steering Committee on Problem Solving Courts. He is a retired Okaloosa County (FL) Court Judge. He served for six years on the Florida Supreme Court’s Task Force on Mental Health and Substance Abuse, and previously served on the statutory Florida Defense Support Task Force and Florida's Suicide Prevention Coordinating Council. He was instrumental in establishing Florida's Veterans Treatment Courts and served four VA Secretaries for more than five years as a member of the VA Readjustment Advisory Committee.
Emerging Applications for Nutritional Ketosis: Implications for HBOT and Safety in Hyperbaric Environments
Dominic D'Agostino, PhD
Dr. Dominic D'Agostino is a Professor in the Department of Molecular Pharmacology and Physiology at the University of South Florida, and Research Scientist at the Institute for Human and Machine Cognition (IHMC).
His laboratory develops and tests metabolic-based strategies for neurological disorders, cancer, and for enhancing safety and resilience of military personnel in extreme environments. His research is supported by the Office of Naval Research
Bob Schmidt is director of the Pro Football Retired Players Association and the guiding vision behind the Home Field Advantage. He is also the Founder and President of the Vince Lombardi Foundation and the Chairman and Chief Executive Officer of Great American Broadband, Inc.
He is the former caretaker of his college football teammate, Hall of Famer Willie Wood, and has been a long-time advocate for former players. He is the former head coach of the Georgetown University Football Team.
HBOT in the treatment of acute concussion
Dr. Daphne Denham, MD
Dr. Daphne Denham is a board certified general surgeon who started practicing wound care and hyperbaric medicine over 10 years ago, to spend more time with her 6 children. Watching the effects of concussions on her children friends, she questioned the "wait and see" approach for acute concussions. Over the past 4 years acute concussions have been her passion. In July 2018 she moved from Chicago to Fargo, ND to continue her quest to change the standard of care for acute concussions. She will be presenting original research suggesting the efficacy of HBOT in the treatment of (TGA REMOVED) in young athletes. Dr. Denham serves a member of Hyperbaric Medicine International's Council on Accreditation.
HBOT in the treatment of chronic Traumatic Brain Injury -- A Review of the Evidence
Dr. Xavier Figueroa, PhD
Dr. Figueroa is co-founder and President of the Brain Health & Healing Foundation, and former Director of Scientific Research at the Restorix Research Institute. Dr. Figueroa has been performing neurological clinical research since 1995 in the field of Alzheimer’s research, as well as basic research in neuron biology, cancer research, bioengineering and the biophysics of water in cells. He is currently the owner and Director of Clinical and Scientific Research of Sciencia Incognita Consulting LLC, a consulting and management firm. Sciencia Incognita focuses on providing expert scientific advice on specialty areas of biology, biotechnology, neurobiology and design of clinical trials and basic research experiments. Dr. Figueroa serves on Hyperbaric Medicine International's Board of Directors.
Improved oxygen utilization with bio-identical signaling technology
Hans Eng, President, Eng3 Corporation
Hans Eng is President and CEO of Eng3 Corporation, a Seattle-based company that produces applied biophysics technology for the US and international markets. His 32 years of experience with advanced medical technologies includes working for Johnson & Johnson in Europe and the formation, growth, and successful sale of a German medical implant company.
Hans has deep experience in research and development, production, and quality assurance for medical devices. An advanced Mechanical Engineering degree from the University of Applied Sciences, Berlin, combined with his background in material science and proteomics enabled Hans to develop the patented technology that underlies Eng3’s NanoVi™ products.
Neurofeedback in the treatment of Neurological Injuries
Dr. Mary Lee Esty, PhD, LCSW
Dr. Esty is a leading researcher and clinician in using bio and neurofeedback for neurological conditions. She is currently an investigator in a large clinical trial for neurofeedback for TBI and PTSD being conducted at the Uniformed Services University for Health Sciences (USUHS). She has published in several professional journals and is the author of Conquering Concussion: Healing TBI Symptoms with Neurofeedback and Without Drugs. Dr. Esty is a Senior Fellow in Biofeedback and Neurofeedback at the Biofeedback Certification International Alliance and is the founder of the Brain Wellness and Biofeedback Center in Bethesda, MD.
Low-Level Light Therapy (LLLT) in the treatment of chronic Traumatic Brain Injury
Dr. Gregory Hipskind, MD, PhD
Dr. Hipskind is a nationally recognized expert in using SPECT brain imaging to evaluate traumatic and toxic brain injuries. He will be presenting original research on a recently-published clinical trial that suggests that LLLT can be used to effectively treat chronic TBI. Dr. Hipskind will also offer insights into the similarities and differences of SPECT brain imaging between chronic TBI patients treated with LLLT and patients treated with (TGA REMOVED)
Use of Advanced Neurodiagnostics and Data Analytics in Pre and Post Treatment Measurement and Efficacy
John A. Kelley, Jr.
John Kelley is the Chairman and CEO of CereHealth Corp., a brain imaging and data analytics company with a proprietary, scalable AI platform. The Company is focused on establishing its position as a world leader in multivariable analysis of quantitative biomarkers for central nervous system (CNS) disorders.
The Company’s CereMetrix™ platform helps solve the problem of untimely, limited information available to physicians and researchers that delays chronic CNS patients receiving access to the right – often life-saving – treatments.
1.2 billion in the world struggle from a brain-based disorder and misdiagnosis rates range from 19% to 69%
Almost 40% of patients receiving mental health treatment dropout due to ineffectiveness
Bringing new brain health-related therapies to market can take up to 10 years and millions of dollars due to flawed protocols, arduous, delayed data analysis and avoidable amendments in clinical research.
CereMetrix’s patented technology and IP uses AI machine learning technologies to provide clinicians and researchers with actionable, real-time insights to quickly and more accurately identify and analyze key biomarkers through its:
Largest database of vetted, structured brain health data collected over a 10-year period
Real-time insights eliminate the need for a team of data scientists
Analysis of multiple datasets to correlate common characteristics among patient populations
Browser-based – access anytime, anywhere technology
Scalable platform that can be applied to multiple brain health datasets
8,000+ CNS patient registry
Cannabis and Brain Health
Michael D. Lewis, MD
Doctor Lewis will lecturing on the role our endogenous cannabinoid system plays in brain health and how nature gives us the opportunity to achieve better balance through the use of omega-3 fatty acids and cannabis, particularly non-psychoactive, broad spectrum industrial hemp.
Michael D. Lewis, MD, MPH, MBA, FACPM, FACN, is an expert on nutritional interventions for brain health, particularly the prevention and rehabilitation of brain injury. In 2012 upon retiring as a Colonel after 31 years in the U.S. Army, he founded the nonprofit, Brain Health Education and Research Institute. He is a graduate of the U.S. Military Academy at West Point and Tulane University School of Medicine. Dr. Lewis is board-certified and a Fellow of the American College of Preventive Medicine and American College of Nutrition. He completed post-graduate training at Walter Reed Army Medical Center, Johns Hopkins University, and Walter Reed Army Institute of Research.
Doctor Lewis is in private practice in Potomac, MD, where he focuses on helping veterans and other patients regain their brain health often months or years after a head injury. He is the author of When Brains Collide: What every athlete and parent should know about the prevention and treatment of concussions and head injuries.
New Tools for Medical Research -- Machine Learning
Dr. James Lyons-Weiler
Dr. Lyons-Weiler is a research scientist and author of “Cures vs. Profits“, “Environmental and Genetic Causes of Autism“, and “Ebola: An Evolving Story”.He founded one of the world’s first Centers for Bioinformatics at UMASS, and helped develop that institutions’ undergraduate and graduate studies curriculum in Bioinformatics. And he produced online software that implemented numerous methods of microarray data analysis. He participated in the NCI’s Early Detection Research Network (EDRN) and their caBIG (Cancer Biomedical Informatics Grid) initiatives. And he served as the founding Editor-in-Chief of his brainchild journal, the open access, rigorously peer-reviewed journal, Cancer Informatics.
Reporting a pilot study on HBOT in TBI
Dr. Robert Mozayeni, MD
Dr. B. Robert Mozayeni is an expert in Translational Medicine, the science and art of advancing medical science safely and efficiently. He is a Fellow of the non-profit Think Lead Innovate Foundation. He is the Chief Medical Officer of Galaxy Diagnostics, LLC. He is a co-founder of the Foundation for the Study of Inflammatory Diseases. And, he recently joined as a founding Board member, the Human-Kind Alliance. He serves as an advisor to Pharma- and Nutra-ceutical companies and serves on an Institutional Review Board specializing in nutraceutical products for pain management.
Low-Level Light Therapy (LLLT)/ Photobiomodulation (PBM) in the treatment of Neurological Injuries
Dr. Margaret Naeser, PhD
Dr. Naeser is a Research Professor in Neurology at the Boston University School of Medicine and a Research Linguist/Speech-Language Pathologist with the Department of Veterans Affairs Boston Healthcare System. She is a globally-recognized leading researcher in LLLT/PBM and has published 25 papers in professional medical journals on research in both LLLT/PBM and transcranial magnetic stimulation (TMS) in the treatment of neurological injuries such as stroke and TBI and in the treatment of chronic pain.
HBOT in the treatment of Autism
Dr. Tami Peterson, PhD
Dr. Peterson has worked as a specialist in autism for nearly three decades. Her doctoral dissertation was on the application of hyperbaric oxygen therapy in the treatment of autism. She is currently the chief executive officer of the Oxford Recovery Center in Brighton, MI, where she has accumulated extensive data on the role of (TGA REMOVED) in helping young children with autism. Dr. Peterson serves as a member of Hyperbaric Medicine International's Council on Accreditation.
Genetic indicators for treatment decisions in Autism
Dr. Christian Bogner, MD
Dr. Bogner is continuously striving to bring forth cutting-edge research for effective therapeutic options. Having lectured both nationally and internationally on autism spectrum disorders, his goal is to optimize each affected individual’s path for recovery by integrating SNP genotyping, neurotransmitter analysis, hyperbaric oxygen, applied behavior analysis and nutrition coaching.
These principles lead him with his team of experts to launch the ARTS (Autism Recovery Thru Synergy) program at the Oxford Recovery Center in Michigan. With the focus on immune dysregulation, methylation genetics, neurotransmitter imbalances, the molecular mechanisms underlying NRF-2 activation, as well as targeting toxic environmental bio-accumulations, root causes are addressed and then individually targeted.
Managing Oxygen Toxicity
Dr. Angela Poff, PhD
Dr. Poffis a Research Associate at the University of South Florida, studying non-toxic metabolic-targeted therapies for cancer and neurological diseases. She specializes in studying low carbohydrate and ketogenic nutrition, including ketogenic diets and exogenous ketone supplements. She has a B.A. in Biochemistry and Molecular Biology from Hendrix College, and a M.S. and Ph.D. in Medical Sciences with a concentration in Molecular Pharmacology and Physiology from the University of South Florida.
HBOT in the treatment of Opioid Dependence
Dr. Raymond Quock, PhD
Dr. Quock is a Professor of Psychology and Affiliate Professor of Neuroscience at Washington State University. He has published over 140 papers on neuropsychopharmacology. He will be presenting original research from a soon-to-be published clinical trial that suggest that HBOT may have a role in mitigating the severity of withdrawal for opioid addiction leading to reduction of daily doses of methadone or buprenorphine.
HBOT in the treatment and Diabetic Foot Ulcers
Dr. Jayesh Shah, MD
Dr. Shah a highly sought after expert in the application of hyperbaric oxygen therapy (HBOT) in wound care and has presented at over 200 national and international conferences. He is the president of the American College of Hyperbaric Medicine. (www.achm.org) He is author of Textbook of Chronic Wound Care: An Evidence-Based Approach to Diagnosis and Treatment (2018), Wound Care Certification Study Guide (2016), twenty published scientific papers, and numerous articles and reviews.